{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:37:39Z","timestamp":1767148659032,"version":"build-2238731810"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA023957"],"award-info":[{"award-number":["DA023957"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.pbb.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T02:07:24Z","timestamp":1538964444000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors"],"prefix":"10.1016","volume":"175","author":[{"given":"Gregory L.","family":"Powell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Vannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuiying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Luedtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet L.","family":"Neisewander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2018.10.002_bb0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.110.167619","article-title":"Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys","volume":"334","author":"Achat-Mendes","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.10.002_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-3057(99)00168-9","article-title":"Gender differences in dopaminergic function in striatum and nucleus accumbens","volume":"64","author":"Becker","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2018.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.euroneuro.2015.06.002","article-title":"Imaging the D3 dopamine receptor across behavioral and drug addictions: positron emission tomography studies with [11C]-(+)-PHNO","volume":"25","author":"Boileau","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2018.10.002_bb0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.npp.1300169","article-title":"Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors","volume":"28","author":"Cervo","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0030","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuropharm.2012.08.011","article-title":"Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats","volume":"63","author":"Cheung","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.112.202911","article-title":"Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55","volume":"347","author":"Cheung","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.10.002_bb0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroscience.2010.04.056","article-title":"Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration","volume":"169","author":"Conrad","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2018.10.002_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.npp.1300148","article-title":"Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A","volume":"28","author":"Di Ciano","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130050496","article-title":"Predictive validity of the extinction\/reinstatement model of drug craving","volume":"135","author":"Fuchs","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0361-9230(03)00217-X","article-title":"Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats","volume":"61","author":"G\u00e1l","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2018.10.002_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00213-013-3254-y","article-title":"The effects of the novel da D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats","volume":"231","author":"Galaj","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/syn.20152","article-title":"Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors","volume":"57","author":"Gilbert","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2018.10.002_bb0070","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/jpet.106.107920","article-title":"Effects of RGH-237 [N\u2011{4\u2011[4\u2011(3\u2011aminocarbonyl-phenyl)\u2011piperazin\u20111\u2011yl]\u2011butyl}\u20114\u2011bromo\u2011benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse","volume":"320","author":"Gyertyan","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.10.002_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","article-title":"Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"Heidbreder","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2018.10.002_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.npp.1300778","article-title":"Sex differences and hormonal influences on acquisition of cocaine self-administration in rats","volume":"31","author":"Jackson","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2014.12.024","article-title":"Differential effects of the dopamine D 3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys","volume":"92","author":"John","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0090","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1021\/jm501512b","article-title":"Identifying medication targets for psychostimulant addiction: unraveling the dopamine D3 receptor hypothesis","volume":"58","author":"Keck","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2018.10.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2017.06.043","article-title":"Dopamine D3 receptor status modulates sexual dimorphism in voluntary wheel running behavior in mice","author":"Klinker","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2018.10.002_bb0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/syn.20666","article-title":"c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues","volume":"63","author":"Kufahl","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2018.10.002_bb0105","series-title":"Dopamine D3 Receptor Knockout Mice Exhibit Abnormal Nociception in a Sex-different Manner","first-page":"1438","volume":"1445","author":"Liu","year":"2017"},{"key":"10.1016\/j.pbb.2018.10.002_bb0110","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/syn.20891","article-title":"Endogenous dopamine (DA) competes with the binding of a radiolabeled D3 receptor partial agonist in vivo: a positron emission tomography study","volume":"65","author":"Mach","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2018.10.002_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02244907","article-title":"Animal models of drug craving","volume":"112","author":"Markou","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0120","series-title":"Further Characterization of Quinpirole-elicited Yawning as a Model of Dopamine D3 Receptor Activation in Male and Female Monkeys","first-page":"205","author":"Martelle","year":"2014"},{"key":"10.1016\/j.pbb.2018.10.002_bb0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2014.03.013","article-title":"Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11 C](+)PHNO","volume":"139","author":"Matuskey","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2018.10.002_bb0130","doi-asserted-by":"crossref","first-page":"11271","DOI":"10.1073\/pnas.91.23.11271","article-title":"Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain","volume":"91","author":"Murray","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2018.10.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1300456","article-title":"Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior","volume":"29","author":"Neisewander","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2013.08.014","article-title":"Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: implications for medications development","volume":"76","author":"Neisewander","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/npp.2013.192","article-title":"Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-(+)-PHNO","volume":"39","author":"Payer","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0150","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/npp.2010.72","article-title":"Stimulation of medial prefrontal cortex serotonin 2C (5-HT2C) receptors attenuates cocaine-seeking behavior","volume":"35","author":"Pentkowski","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.10.002_bb0155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/22560","article-title":"Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist","volume":"400","author":"Pilla","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2018.10.002_bb0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jnc.12825","article-title":"Characterization of [3H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand","volume":"131","author":"Rangel-Barajas","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2018.10.002_bb0165","series-title":"Animal Models of Drug Addiction","first-page":"233","article-title":"Self-administration of psychomotor stimulants using progressive ratio schedules of reinforcement","author":"Roberts","year":"1992"},{"key":"10.1016\/j.pbb.2018.10.002_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.pbb.2018.10.002_bb0175","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.euroneuro.2014.08.014","article-title":"Neurobiological basis of motivational deficits in psychopathology","volume":"25","author":"Salamone","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2018.10.002_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2017.03.013","article-title":"The phasic dopamine signal maturing: from reward via behavioural activation to formal economic utility This review comes from a themed issue on Neurobiology of learning and plasticity","volume":"43","author":"Schultz","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pbb.2018.10.002_bb0185","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2018.10.002_bb0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pbb.2018.10.002_bb0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1369-1600.2011.00317.x","article-title":"YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self\u2010administration in rats and mice, but not in D3 receptor\u2010knockout mice","volume":"17","author":"Song","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2018.10.002_bb0200","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996","article-title":"Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities","volume":"16","author":"Staley","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2018.10.002_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.117.241141","article-title":"Effects of acute and chronic treatments with dopamine D 2 and D 3 receptor ligands on cocaine versus food choice in rats","volume":"362","author":"Thomsen","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.10.002_bb0210","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/jm101323b","article-title":"Synthesis and pharmacological evaluation of fluorine-containing D 3 dopamine receptor ligands","volume":"54","author":"Tu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2018.10.002_bb0215","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002","article-title":"Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats","volume":"22","author":"Vorel","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2018.10.002_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrn.2016.39","article-title":"Synaptic mechanisms underlying persistent cocaine craving","volume":"17","author":"Wolf","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2018.10.002_bb0225","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.npp.1300912","article-title":"The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats","volume":"31","author":"Xi","year":"2006","journal-title":"Neuropsychopharmacology"}],"updated-by":[{"DOI":"10.1016\/j.pbb.2018.05.015","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718304957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718304957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T09:45:31Z","timestamp":1542966331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718304957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":45,"alternative-id":["S0091305718304957"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2018.10.002","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}